- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/06 - Tripeptides
Patent holdings for IPC class A61K 38/06
Total number of patents in this class: 1903
10-year publication summary
149
|
186
|
155
|
187
|
182
|
140
|
168
|
139
|
148
|
37
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
57 |
Stealth Biotherapeutics Inc. | 143 |
34 |
Alastin Skincare, Inc. | 79 |
19 |
DSM IP Assets B.V. | 5856 |
18 |
Bristol-myers Squibb Company | 5080 |
17 |
Kyowa Hakko Bio Co., Ltd. | 296 |
17 |
The Regents of the University of California | 18943 |
15 |
The Regents of the University of Michigan | 4409 |
15 |
Agency for Science, Technology and Research | 3512 |
15 |
Transdermal Biotechnology, Inc. | 68 |
14 |
Cornell University | 3036 |
13 |
Onyx Therapeutics, Inc. | 71 |
13 |
Biohaven Therapeutics Ltd. | 88 |
12 |
Telik, Inc. | 26 |
11 |
The Johns Hopkins University | 5377 |
10 |
ISP Investments Inc. | 485 |
10 |
L.e.a.f. Holdings Group LLC | 93 |
10 |
F. Hoffmann-La Roche AG | 7958 |
9 |
The General Hospital Corporation | 4517 |
9 |
Abbvie Inc. | 1808 |
9 |
Other owners | 1576 |